v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
 9 Months Ended
May 31, 2026
May 31, 2025
Cash flows from operating activities    
Net loss from continuing operations $ (1,856,583) $ (1,721,429)
Net loss from discontinued operations   (30,440)
Adjustments to reconcile net loss to net cash flows used in operating activities:    
Depreciation 13,715 5,096
Stock based compensation expense 103,125
Changes in operating assets and liabilities:    
Deferred research and development costs 26,471 (25,061)
Prepaid expenses and other assets (30,772) 593,444
Accounts payable and accrued expenses 79,677 86,978
Related party payable 32,512 (15,398)
Net cash used in operating activities (1,734,980) (1,003,685)
Cash flows from investing activities    
Redemption of short-term investments 3,000,000
Capital expenditures (31,350) (8,091)
Net cash (used) provided by investing activities (31,350) 2,991,909
Net (decrease) increase in cash and cash equivalents (1,766,330) 1,988,224
Cash and cash equivalents at beginning of period 6,555,642 1,249,446
Cash and cash equivalents at end of period $ 4,789,312 $ 3,237,670